A quality analyst runs the same peptide sample twice in one sequence, once near the start and once eleven hours later at the end. The first chromatogram shows a single small impurity. The second shows that impurity slightly larger and a new shoulder beside the main peak. The instrument passed its checks, the column is fine, and the method has not changed. What changed was the sample, sitting dissolved in the autosampler tray all day.
Most discussions of HPLC purity focus on columns, gradients and integration. Yet a large share of odd results trace back to the minutes and hours between opening a container and loading the sample onto the column. None of that work normally appears on a test report. This article walks through where analytical sample preparation can alter a peptide result, and how analysts detect it.
The working rule: re-prepare before you re-interpret
When a chromatogram looks wrong, the most efficient first step is usually to prepare a fresh sample carefully and run it promptly. If the anomaly disappears, the preparation was responsible. If it persists, attention can return to the material itself. The sections below explain why this rule works.
Getting a lyophilized solid into solution
A freeze-dried peptide has to be dissolved before it can be analyzed, and the choice of solvent is an analytical decision. Water suits many sequences but not all. Solubility depends on net charge at the chosen pH: acidic sequences tend to dissolve poorly at low pH, basic ones at high pH, and amphipathic sequences may need a small proportion of organic solvent. Background on the solid form is in what is a lyophilized peptide.
Forcing a difficult sample into solution has a cost. Ultrasonic baths can raise local temperature and generate reactive species, and warming accelerates whatever degradation routes the sequence has. An analyst who had to work hard to dissolve a sample should consider whether the sample analyzed is still representative of the solid.
Sample solvent strength and peak distortion
This is the most common preparation fault, and it leaves a recognizable fingerprint. In gradient reverse-phase HPLC, the sample is supposed to focus in a narrow band at the head of the column while the mobile phase is still weak. If the sample solvent contains more organic solvent than the starting mobile phase, that focusing fails. The analyte begins moving immediately, spread across the whole volume loaded.
The result is fronting, split peaks or broadening, and the effect grows with the volume loaded. Matching the sample solvent to the starting mobile-phase composition, or making it weaker, removes the problem. A distorted peak that becomes sharp once the sample is prepared in a weaker solvent was reporting on the preparation, not on the peptide.
Where peptide goes missing
Surface adsorption
Peptides adsorb to container walls, and cationic sequences bind especially readily to glass and some plastics. At high concentration the loss is negligible. At low concentration a significant fraction of the weighed material can end up on the vial wall. Two consequences follow. Low apparent content does not necessarily mean degradation. And because different species adsorb to different extents, adsorption can change the measured ratio of main peak to impurity. Low-binding vials and a small organic fraction in the solvent both reduce the effect.
Filtration
Filtering removes particles that would damage a column, but membranes also bind peptide. The amount depends on membrane material, filter area and concentration. The standard precaution is to discard the first portion of filtrate, which saturates binding sites so that the collected fraction reflects the original composition. Skipping that step with a dilute sample can remove a measurable share of analyte, sometimes selectively. When the only aim is to remove particles, centrifugation avoids membrane contact altogether.
Time in the autosampler
Long sequences mean that the last samples may sit in solution for many hours before analysis. For a peptide with a fast degradation route, that is enough time for real chemistry to occur. Typical examples include oxidation of a free thiol, cyclization of an N-terminal glutamine to pyroglutamate, and deamidation of an asparagine. The opening scenario is an example of this: the impurity growth was genuine, but it happened in the tray, not in the original material.
Two controls help. Cooling the autosampler slows most of these reactions. Bracketing, meaning repeat runs of the same solution at the start and end of the sequence, detects them: if the bracketing results differ, something changed in solution during the run.
Too much sample on the column
Overloading saturates the stationary phase locally. The main peak fronts and broadens, and resolution between the main peak and closely eluting impurities suffers exactly where it matters most. Overload is easy to confirm because it depends on amount. Load half as much and run again: the area should halve and the peak shape should improve. If the shape does not improve, overload was not the cause.
A preparation checklist
| Symptom | Likely preparation cause | Quick check |
|---|---|---|
| Fronting or split main peak | Sample solvent stronger than starting mobile phase | Re-prepare in weaker solvent and compare |
| Low total area, no new peaks | Adsorption to vial or filter | Use low-binding vials; compare filtered and centrifuged aliquots |
| Impurities grow across the sequence | Degradation in solution over time | Compare bracketing runs; cool the tray |
| Broad peak, poor resolution | Column overload | Halve the amount loaded |
| New peaks after difficult dissolution | Heat or sonication damage | Prepare gently from fresh solid |
Why reports leave this out
Sample preparation is usually regarded as internal method detail rather than a reportable result, so a report may specify the column and gradient while saying nothing about solvent, concentration or filtration. That is a universal convention, not a failing of any particular laboratory. It does mean preparation is one more reason two competent laboratories can obtain different purity figures for the same material, alongside the factors covered in why suppliers report different peptide purity. When the details matter, the questions in HPLC method questions for a peptide supplier are a reasonable place to start.
Questions
Why does a peak look better after diluting the sample in water?
Usually because the original sample solvent was stronger than the starting mobile phase, which prevented the analyte from focusing at the head of the column.
Can adsorption change a purity percentage?
Yes. If the main peptide and an impurity adsorb to different degrees, the ratio that reaches the column differs from the ratio in the original material.
How can an analyst tell whether a sample degraded during a sequence?
By bracketing: running the same solution at the beginning and end of the sequence and comparing the impurity profiles.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.